Semis, Bitcoin Help Fuel Market Climb … And The Insmed CEO on Trial Results 6/10/25
CNBC's "Fast Money"
00:00
Navigating Growth and Independence in Biotech
This chapter examines the growth trajectory of a biotech company that expanded from 25 to 1,500 employees and achieved approval for three key medicines. It also discusses the company's strategic choices regarding independence versus potential sale while reflecting on the impact of its innovations on healthcare.
Transcript
Play full episode
